University Of Nairobi
Clinical trials sponsored by University Of Nairobi, explained in plain language.
-
HIV drug resistance: which treatment strategy wins?
Disease control Recruiting nowThis study looks at people with HIV whose current medication (dolutegravir) is no longer working well due to drug resistance. It compares two options: staying on dolutegravir or switching to a different drug (darunavir boosted by ritonavir). The goal is to see which approach bett…
Phase: PHASE3 • Sponsor: University of Nairobi • Aim: Disease control
Last updated May 26, 2026 06:03 UTC
-
HIV resistance study seeks answers for better treatment
Knowledge-focused Recruiting nowThis study looks at how well people with HIV who have developed resistance to the drug dolutegravir can suppress the virus with current treatments. Researchers will track 6,600 participants across multiple countries to understand resistance patterns and improve care. The goal is …
Sponsor: University of Nairobi • Aim: Knowledge-focused
Last updated May 26, 2026 06:05 UTC